Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Ryan Savitz, Executive Vice President, Chief Financial Officer, and Chief Business Officer of Dianthus Therapeutics, Inc. (NASDAQ:DNTH), executed a series of transactions involving the sale of 31,249 shares of common stock on July 9, 2026, totaling approximately $3.16 million. The sales were conducted under a Rule 10b5-1 trading plan adopted on Dec…
Todd Dzyak, Chief Operating Officer of WidePoint Corporation, executed a sale of 5,000 shares of the company's common stock on July 9, 2026. The transaction was valued at $63,750, with each share sold at $12.75. This divestment reduces Dzyak's direct holdings to 110,436 shares. The sale comes as WidePoint reports improved Q1 2026 financial results,…
Michael George Rosenbaum, Chief Executive Officer of Guidewire Software, Inc. (NASDAQ:GWRE), sold 1,200 shares of the company's common stock on July 13, 2026. The transaction, valued at $166,164, was executed automatically under a 10b5-1 trading plan adopted on October 14, 2025. Following the sale, Rosenbaum directly holds 194,976 shares. The sale …
BridgeBio Pharma, Inc. (NASDAQ: BBIO) director Andrea Ellis executed a sale of $1,442,028 in company stock on July 9, 2026. The transaction, covering 17,167 shares at $84.00 per share, was conducted under a pre-established Rule 10b5-1 plan adopted in December 2025. This sale coincides with a period of significant corporate activity for BridgeBio, i…
Richard McCathron, Chief Executive Officer of Hippo Holdings Inc. (NASDAQ: HIPO), executed a sale of 5,000 shares of common stock on July 9, 2026, generating proceeds of $142,650. The transaction, priced at $28.53 per share, was conducted under a Rule 10b5-1 trading plan established on August 29, 2025. Following the sale, McCathron retains a direct…
Wilfred T. O’Gara, a director at LSI Industries Inc. (NASDAQ:LYTS), executed a significant divestment of 10,369 common shares on June 1, 2026, realizing approximately $249,789. This transaction reduces his direct holdings, including a joint account with his spouse, to 103,686 shares. The sale occurs against a backdrop of strong operational performa…
Jennifer E. Cook, a director at BridgeBio Pharma, Inc. (NASDAQ: BBIO), executed a series of complex transactions on July 9, 2026, involving the sale and acquisition of company stock. The director sold 148,589 shares valued at approximately $13.16 million under a Rule 10b5-1 plan, while simultaneously acquiring an equal number of shares through stoc…
Oguzhan Atay, Chairman and Chief Executive Officer of BillionToOne, Inc. (NASDAQ:BLLN), executed a sale of 12,500 shares of Class A Common Stock on July 9, 2026, realizing approximately $1.57 million in proceeds. The transactions were facilitated through a pre-existing Rule 10b5-1 trading plan established in March 2026. Despite the executive divest…
A consortium of reporting owners, including Aqua Capital, Ltd. and Durango Capital, Ltd., has acquired 60,000 shares of Energizer Holdings, Inc. (NASDAQ: ENR) for approximately $1.23 million. The transactions, executed on July 9 and July 10, 2026, bring the group's direct and indirect ownership to 7,480,000 shares, solidifying their status as a gre…
BillionToOne, Inc. (NASDAQ:BLLN) Chief Product Officer Sakakibara Shan Riku completed a $1,000,000 sale of 8,000 Class A Common Stock shares on July 9, 2026. The transaction, executed at $125 per share, was facilitated through a Rule 10b5-1 trading plan established on March 6, 2026. Concurrently, Sakakibara exercised fully vested stock options to a…
Datadog, Inc. (NASDAQ:DDOG) director Amit Agarwal has executed a significant sale of Class A Common Stock shares. The transaction, valued at approximately $5.35 million, was carried out through a pre-arranged trading plan. This activity occurs as the company faces contrasting analyst outlooks and continues its strategic focus on artificial intellig…
David A. Duffield, a principal 10% shareholder of Workday Inc., offloaded 107,500 Class A Common Stock shares on July 9, 2026, generating approximately $14.7 million in proceeds. The transaction, facilitated through a Rule 10b5-1 trading plan linked to a 2025 trust arrangement, involved converting an equal number of Class B shares prior to sale. Th…
Darin Lippoldt, the Chief Legal Officer at Neurocrine Biosciences Inc. (NASDAQ: NBIX), executed a sale of 10,000 shares of the company's common stock on July 9, 2026, totaling approximately $1.79 million. The transaction was conducted under a Rule 10b5-1 trading plan established prior to the sale. This activity occurs as the company navigates a per…
Grace & Mercy Foundation, Inc. has increased its direct ownership in Gloo Holdings, Inc. (NASDAQ:GLOO) through a recent purchase of Class A Common Stock. The transaction, executed as part of a broader firm commitment underwritten public offering, underscores the foundation's continued capital allocation into the company. This activity occurs agains…
Ooma Inc. CEO Eric Stang executed a direct sale of company stock in July, while the firm recently delivered fiscal 2027 first-quarter results that beat consensus estimates on earnings, revenue, and EBITDA. Following these financial beats, management raised its full-year outlook, and multiple investment firms adjusted their price targets upward or r…
Twist Bioscience Corp (NASDAQ:TWST) CFO Adam Laponis completed a non-discretionary sale of 2,399 shares on July 9, 2026, generating $226,307 to fulfill tax withholding duties tied to Restricted Stock Unit vesting. The transaction occurs amid a 9.3% weekly stock decline and heightened market volatility, even as analyst firms highlight the company’s …
HRT Financial LP, recognized as a 10% owner of Bluejay Diagnostics, Inc. (NASDAQ:BJDX), disclosed a combination of purchase and sale activity for the company's common stock. The firm sold shares valued at $48,913 while simultaneously acquiring stock worth $96,710. These transactions take place against a backdrop of recent corporate developments, in…
HRT Financial LP has increased its position in Shuttle Pharmaceuticals Holdings, Inc. through recent share purchases. The acquisition occurs as Shuttle Pharmaceuticals navigates significant corporate changes, including a completed merger and an approved reverse stock split. The company's stock has experienced substantial declines over recent period…
QNB Corp. director Joseph W Major recently increased his stake in the company through a targeted purchase of common stock, according to regulatory filings. The transaction underscores continued executive confidence as the financial institution advances its operational integration and maintains a long-standing dividend record. This activity occurs w…
Azar Samak L, the Chief Legal Officer at GLOBALFOUNDRIES Inc. (NASDAQ:GFS), recently executed a sale of 335 ordinary shares on July 9, 2026, generating proceeds of $23,751. The transaction, conducted at a price of $70.90 per share, was carried out under a Rule 10b5-1 trading plan previously established by the executive. Following this sale, Samak L…
Atlas Infrastructure Partners (UK) Ltd. executed a strategic acquisition of H2O America (NASDAQ:HTO) shares on July 7, 2026, reinforcing its position as a significant shareholder. This transaction occurs against a backdrop of mixed Q1 2026 financial performance for HTO, where earnings and revenue fell short of analyst expectations, yet market react…
Horizon Kinetics Asset Management LLC has increased its direct holding in Texas Pacific Land Corp (NYSE: TPL) through a recent purchase, while the energy and land management company reported first-quarter 2026 financial results that exceeded analyst expectations. The acquisition occurs alongside a strategic agreement with Chevron for Project Kilby …
Horizon Kinetics Asset Management LLC, which serves as the investment adviser to RENN Fund, Inc., executed a recent acquisition of the fund's common stock. The transaction, valued at $2,283, involved the purchase of 756 shares on July 10, 2026, bringing the firm's total direct holding to 933,420 shares. As a significant 10% owner, Horizon Kinetics …
Peter R. Matt, President and CEO of Commercial Metals Co (NYSE:CMC), increased his direct ownership stake through a recent equity purchase. The transaction occurred alongside the company reporting fiscal third-quarter 2026 financial metrics that surpassed consensus estimates. While management activity and earnings strength suggest internal confiden…
Jorey Chernett, a significant 10% shareholder in The Oncology Institute, Inc. (NASDAQ: TOI), executed a direct purchase of 15,000 shares on July 10, 2026, valued at $87,750. This transaction brings Chernett's total holding to 10,630,858 shares. The insider buying activity occurs as TOI trades near its 52-week high of $6.11, supported by recent corp…
